Adrienne Graves
Directeur/Bestuurslid bij NICOX SA
Vermogen: 100 800 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Adrienne Graves
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
The Foundation Fighting Blindness, Inc.
 The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD.
82
| Non-Profit Organization | Miscellaneous Commercial Services | 82 |
American Academy of Ophthalmology, Inc.
 American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets.
36
| Non-Profit Organization | Miscellaneous Commercial Services | 36 |
| Holding Company | Medical Specialties | 31 | |
29
| Extinct | Pharmaceuticals: Major | 29 |
The Association for Research in Vision & Ophthalmology
 The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services The Association for Research in Vision & Ophthalmology operates an association focused on research in vision and ophthalmology. The non-profit company is based in Rockville, MD.
28
| Non-Profit Organization | Miscellaneous Commercial Services | 28 |
| Public Company | Medical/Nursing Services | 27 | |
| Public Company | Pharmaceuticals: Major | 20 | |
The American Society of Cataract & Refractive Surgery
19
| Non-Profit Organization | 19 | |
| Subsidiary | Pharmaceuticals: Generic | 19 | |
17
| Public Company | Pharmaceuticals: Major | 17 |
Women in Ophthalmology, Inc.
 Women in Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Ophthalmology, Inc. provides support to ophthalmologists. It offers professional development, carrier advancement, and interactive networking to its members. The company is headquartered in Denver, CO.
14
| Non-Profit Organization | Miscellaneous Commercial Services | 14 |
Implandata Ophthalmic Products GmbH
 Implandata Ophthalmic Products GmbH Electronic Equipment/InstrumentsElectronic Technology Implandata Ophthalmic Products GmbH develops diagnosis tool for glaucoma therapy. Its technology Pro-IOP is an eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing, an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage and a GSM module which can be connected with the hand held device for transfer of measurement data to a database, which can be accessed by the eye doctor in order to get information about the disease status of the patient. The company was founded by Max Georg Ostermeier and Stefan Meyer in January 2010 and is headquartered in Hannover, Germany.
11
| Holding Company | Electronic Equipment/Instruments | 11 |
11
| Public Company | Pharmaceuticals: Major | 11 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX.
11
| Subsidiary | Medical Specialties | 11 |
| Public Company | Pharmaceuticals: Major | 9 | |
Retinal Degeneration Fund
9
| Subsidiary | 9 | |
Surface Ophthalmics, Inc.
 Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA.
7
| Holding Company | Biotechnology | 7 |
Qlaris Bio, Inc.
 Qlaris Bio, Inc. BiotechnologyHealth Technology Qlaris Bio, Inc. operates as a biotechnology company. The company was founded by Thurein Htoo and Barbara Wirostko and is headquartered in Wellesley, MA.
6
| Holding Company | Biotechnology | 6 |
Himalayan Cataract Project
5
| Non-Profit Organization | 5 | |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC.
5
| Holding Company | Biotechnology | 5 |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Glaucoma Research Foundation
 Glaucoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Glaucoma Research Foundation provides education services. The non-profit company is based in San Francisco, CA. The company was founded by Adrienne L. Graves. The CEO is Thomas M. Brunner.
4
| Non-Profit Organization | Miscellaneous Commercial Services | 4 |
Opus Genetics, Inc.
 Opus Genetics, Inc. BiotechnologyHealth Technology Opus Genetics, Inc. is a gene therapy company that focuses on treating inherited retinal diseases. The company is based in Raleigh, NC, and leverages knowledge of the best science and the expertise of pioneers in ocular gene therapy to transparently drive transformative treatments to patients. The company has a unique model and purpose, and is backed by Foundation Fighting Blindness's venture arm, the RD Fund. Opus Genetics has wholly owned programs in numerous orphan retinal diseases, and its AAV-based gene therapy portfolio tackles some of the most neglected forms of inherited blindness while creating novel orphan manufacturing scale and efficiencies. The company was founded in 2021 by Benjamin R. Yerxa, Peter L. Ginsberg, Jason D. Menzo, Jean Bennett, Russell Kelley, Jean Bennett. Benjamin R. Yerxa has been the CEO since 2021.
4
| Holding Company | Biotechnology | 4 |
American Society of Cataract & Refractive Surgery Foundation
3
| Non-Profit Organization | 3 | |
American Glaucoma Society
 American Glaucoma Society Investment Trusts/Mutual FundsMiscellaneous The American Glaucoma Society supports glaucoma specialists and scientists through the advancement of education and research.
2
| Non-Profit Organization | Investment Trusts/Mutual Funds | 2 |
KeepYourSight Foundation
 KeepYourSight Foundation Investment Trusts/Mutual FundsMiscellaneous KeepYourSight Foundation provides e-health initiative in the fight against blindness. The company is headquartered in united States.
2
| Foundation/Endowment | Investment Trusts/Mutual Funds | 2 |
Pan-American Ophthalmological Foundation
2
| Foundation/Endowment | 2 | |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017.
2
| Subsidiary | Medical Specialties | 2 |
Retina Global
1
| Private Company | 1 | |
NVasc, Inc.
 NVasc, Inc. Medical SpecialtiesHealth Technology NVasc, Inc. is an early-stage ophthalmology company founded in February 2019 and funded by Kairos Ventures in November 2019. The company is based in Atherton, CA. The company is focused on treating the leading causes of blindness through choroidal and retinal revascularization. The company is planning to manufacture NVB001 that can be used in toxicokinetic studies and in early clinical trials in humans. NVasc has acquired the research rights to growth factors (NVB001 and NVB002) that have been shown to encourage the growth of non-leaking new vessels in the retina and choroid in mouse models of ischemic eye diseases.
1
| Holding Company | Medical Specialties | 1 |
American Academy of Ophthalmology Foundation
1
| Foundation/Endowment | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Adrienne Graves via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
| SURMODICS, INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ALIGN TECHNOLOGY, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
American Medical Association
 American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALCON INC. | Medical Specialties | Director/Board Member President Director/Board Member | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Founder | |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
WaveTec Vision Systems, Inc.
 WaveTec Vision Systems, Inc. Electronic ComponentsElectronic Technology WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA. | Electronic Components | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Graduate Degree | |
| Stanford University | College/University | Masters Business Admin Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| University of Aberdeen | College/University | Undergraduate Degree Doctorate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| Indiana University | College/University | Masters Business Admin Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of Delaware | College/University | Masters Business Admin Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Gund Investment Corp.
 Gund Investment Corp. Investment ManagersFinance Gund Investment Corp. (Gund Investment) is a venture capital firm founded in 1968 by Gordon Gund. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Chief Executive Officer President | |
International Intra-Ocular Implant Club
 International Intra-Ocular Implant Club Miscellaneous Commercial ServicesCommercial Services The International Intra-Ocular Implant Club is a research organization that focuses on the field of intraocular lens implantation. | Miscellaneous Commercial Services | President President | |
| Macula Society | Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
| The Retina Society | Corporate Officer/Principal President Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | ||
| American Society of Retinal Specialists | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal | ||
Sheba Medical Center
 Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
International Society of Refractive Surgery
 International Society of Refractive Surgery Miscellaneous Commercial ServicesCommercial Services Part of American Academy of Ophthalmology, Inc., International Society of Refractive Surgery (ISRS) is an international society that focuses on refractive surgery. The company is based in San Francisco, CA. ISRS offers various resources such as meetings, webinars, and a multimedia library to its members. Members can also benefit from discounts on editing services for the Journal of Refractive Surgery and article processing charges for open-access articles. ISRS also provides an externship program for members to work alongside world-renowned refractive and cataract surgeons. The company hosts an annual meeting, the Refractive Surgery Subspecialty Day, where members can learn about the latest topics in cataract, refractive, and lens-based surgery. | Miscellaneous Commercial Services | President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Director/Board Member Founder | |
| New England Ophthalmological Society | Corporate Officer/Principal President | ||
The European Society of Cataract & Refractive Surgeons
 The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services The European Society of Cataract & Refractive Surgeons, founded in 1991, presents "The Innovators Den: EyeCare Pioneers" at ESCRS iNovation® Day 2023. The non-profit company is based in Dublin, IE and has subsidiaries in United Kingdom. Applications for the event are now open. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
OSG MVZ Betriebs GmbH
 OSG MVZ Betriebs GmbH Specialty StoresRetail Trade OSG MVZ Betriebs GmbH engages in the production and distribution of eyewear. It offers diagnostic tests, which include endothelial biomicroscopy, ultrasound, laser retinometer, corneal thickness measurement, lens calculation, vascular imaging, and intraocular pressure. The firm also provides ophthalmic treatments and medical care services. The company was founded by Manuel Ober and Armin Scharrer in 1982 and is headquartered in Fuerth, Germany. | Specialty Stores | Chief Executive Officer Chief Executive Officer | |
| Euro-Augen-Laser Klinik GmbH | Founder Founder | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Keck School of Medicine of USC
 Keck School of Medicine of USC Other Consumer ServicesConsumer Services The Keck School of Medicine of USC is a place of dynamic activity in patient care, scientific discovery, medical and bioscience education, and community service. Their faculty, staff, students, residents, alumni, donors and friends are committed to excellence. Together they are poised to lead medicine in the 21st Century for the benefit of humankind. This is an exciting time of great transformation as they endeavor to create a truly stellar academic medical center at USC. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Nacuity Pharmaceuticals, Inc.
 Nacuity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nacuity Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VSDAR eV | President Founder | ||
| EUROEYES INTERNATIONAL EYE CLINIC LIMITED | Medical/Nursing Services | Chief Executive Officer Corporate Officer/Principal | |
Visus Therapeutics, Inc.
 Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman Founder | |
| New York University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Miscellaneous Commercial Services | Sales & Marketing Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 40 |
| Duitsland | 5 |
| Zwitserland | 3 |
| Canada | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Consumer Services | 17 |
| Health Technology | 16 |
| Commercial Services | 6 |
| Health Services | 5 |
| Finance | 3 |
Operationeel
| Director/Board Member | 394 |
| Corporate Officer/Principal | 288 |
| Founder | 103 |
| President | 84 |
| Independent Dir/Board Member | 79 |
Sterkste connecties
| Insiders | |
|---|---|
| Richard Lindstrom | 50 |
| Mark Baum | 36 |
| Mark Blumenkranz | 36 |
| Jørn Slot Jørgensen | 28 |
| David Guyer | 27 |
| Michael Weiser | 26 |
| Charles Warden | 24 |
| Peter John McDonnell | 19 |
| Leslie Williams | 19 |
| Alan D. Weinstein | 19 |
| Teresa Sparks | 18 |
| George W. Rozakis | 18 |
| Jean-François Labbé | 18 |
| Timothy Sear | 18 |
| Pravin Dugel | 17 |
- Beurs
- Insiders
- Adrienne Graves
- Bedrijfsconnecties
